2017
DOI: 10.19163/1994-9480-2017-1(61)-54-58
|View full text |Cite
|
Sign up to set email alerts
|

Experimental Study of Dose-Dependent Endotheliotropic Effect of Atacl in Ischemic Brain Damage in Rats

Abstract: The study found that the ATACL compound has the most pronounced endotelioprotective effect when administered at a dose of 100 mg/kg. The pharmacological effect of the administration of this dose of ATACL was comparable with the effect of sulodexide Key words: cerebral ischemia, endothelial dysfunction, antioxidants, endotheliolpathy.Нарушения мозгового кровообращения, в част-ности инсульт, на сегодняшний день, представляют ог-ромную медико-социальную проблему [3]. Несмотря на существенные успехи ангионеврологи… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 4 publications
0
1
0
Order By: Relevance
“…For instance, Pozdnyakov et al (2018) noted that under conditions of cerebral ischemia, the use of ATACL at a dosage of 100 mg/ kg contributed to the normalization of pro/antioxidant equilibrium by increasing the activity of superoxide dismutase, catalase and glutathione peroxidase, as well as by suppressing free radical lipid oxidation reactions, which can indicate a decrease in the concentration of diene adducts and TBA-active compounds, when using 4-hydroxy-3,5-di-tert-butyl cinnamic acid. In this case, the metabolic action of the ATACL compound can be aimed at stabilizing the mitochondrial function, which is realized through the normalization of the activity of mitochondrial subcomplexes V (F 1 F 0 ATP synthase) and IV (cytochrome c oxidase) (Voronkov et al 2018).…”
Section: Discussionmentioning
confidence: 99%
“…For instance, Pozdnyakov et al (2018) noted that under conditions of cerebral ischemia, the use of ATACL at a dosage of 100 mg/ kg contributed to the normalization of pro/antioxidant equilibrium by increasing the activity of superoxide dismutase, catalase and glutathione peroxidase, as well as by suppressing free radical lipid oxidation reactions, which can indicate a decrease in the concentration of diene adducts and TBA-active compounds, when using 4-hydroxy-3,5-di-tert-butyl cinnamic acid. In this case, the metabolic action of the ATACL compound can be aimed at stabilizing the mitochondrial function, which is realized through the normalization of the activity of mitochondrial subcomplexes V (F 1 F 0 ATP synthase) and IV (cytochrome c oxidase) (Voronkov et al 2018).…”
Section: Discussionmentioning
confidence: 99%